|
18 |
|
COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant
|
Martínez-López J |
de la Cruz J, Gil-Manso R, Yuste VJ, Aspa-Cilleruelo JM, Escobar CE, López-Jiménez J, Duarte R, Yerovi CJ, Hernández-Rivas JÁ, Herráez R, Quiroz-Cervantes K, Bustelos-Rodriguez R, Benavente C, Martínez Barranco P, Bastos Oteiro M, Alegre A, Pérez-Oteyza J |
Cancers |
|
17 |
|
COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study
|
Martínez-López J, Diez-Martín JL, García-Suárez J. |
De la Cruz J, Gil-Manso R, Alegre A, Ortiz J, Llamas P, Martínez Y, Hernández-Rivas JÁ, González-Gascón I, Benavente C, Estival Monteliu P, Jiménez-Yuste V, Canales M, Bastos M, Kwon M, Valenciano S, Callejas-Charavia M, López-Jiménez J, Herrera P, Duarte |
Cancers |
|
16 |
|
Incidence and clinical profile of venous thromboembolism in hospitalized COVID-19 patients from Madrid region
|
Arribalzaga K |
Martínez-Alfonzo I, Díaz-Aizpún C, Gutiérrez-Jomarrón I, Rodríguez M, Castro Quismondo N, Pérez-Fernández E, Velasco-Rodríguez D, Gómez E, Fernández B, Vilches A, Martín-Herrero S, Castilla L, Blanco MJ, Gutiérrez MDM, Rivas I, Pascual C, Rosado B, Sola E |
Thrombosis Research |
|
15 |
|
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study
|
Julio Gª-Suarez, Jose Luis Diez-Martin y Joaquin Martinez-Lopez |
Julio García-Suárez 1 , Javier de la Cruz, Ángel Cedillo, Pilar Llamas, Rafael Duarte, Víctor Jiménez-Yuste, José Ángel Hernández-Rivas, Rodrigo Gil-Manso, Mi Kwon, Pedro Sánchez-Godoy, Pilar Martínez-Barranco, Blanca Colás-Lahuerta, Pilar Herrera, Laur |
Journal of Hematology & Oncology |
